Equities researchers at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.01 on Tuesday. The company has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.01. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $2.47. The stock has a market capitalization of $11,400.00, a PE ratio of 0.00 and a beta of 3.66.
About Ampio Pharmaceuticals
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- The Risks of Owning Bonds
- Merck: 4 No-Brainer Reasons to Buy This Dip
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Use the MarketBeat Dividend Calculator
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
